By proceeding, you agree to our Terms of Use and Privacy Policy.
Built with Genentech, AstraZeneca, Starpharma, Avidity, and Guardian Therapeutics, join 80+ key leaders and decision makers as they reimagine traditional ADCs and discuss their novel format technologies.
The Novel Format Conjugates Summit will engage 20 Expert Speakers to discuss the advanced science shaping Bispecific ADCs, Radio-conjugates, ISACs, SMDCs & more.
Discuss upon topics like bicycle conjugates to target solid tumors, utilizing ADCs as conditioning agents, radiopharmaceutical therapies in oncology & more.
Indulge in exclusive pre-conference workshops on - Assessing Regulatory Pathway for an Alternative Format Conjugate, Integrated Development of Novel Format Conjugates.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Theratechnologies is a commercial-stage biopharmaceutical company. We currently market prescription products in the United States, Europe and Canada.
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.